🇺🇸 FDA
Pipeline program

Preservative-free, ophthalmic solution

LT10430-201

Phase 2 small_molecule active

Quick answer

Preservative-free, ophthalmic solution for Paediatric myopia is a Phase 2 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Laboratoire HRA Pharma
Indication
Paediatric myopia
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials